Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$2.00
+1.5%
$1.80
$1.42
$12.33
$73.35M1.4594,869 shs455,089 shs
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$0.97
-2.2%
$0.96
$0.58
$1.39
$76.36M0.93128,943 shs64,310 shs
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
$5.70
-13.0%
$3.94
$1.32
$7.31
$37.52MN/A159,410 shs1.37 million shs
Zynex, Inc. stock logo
ZYXI
Zynex
$2.59
+8.4%
$2.26
$1.66
$10.62
$78.32M0.7161,585 shs300,934 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
+1.52%-6.10%+6.95%+1.01%-81.82%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-2.21%-7.33%-1.72%+3.18%+29.73%
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
-13.51%+21.02%+89.37%+183.58%+569,999,900.00%
Zynex, Inc. stock logo
ZYXI
Zynex
+8.37%+4.86%+7.47%-65.09%-75.38%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
3.8693 of 5 stars
3.32.00.04.33.40.01.3
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/AN/AN/AN/AN/A
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/AN/AN/AN/AN/AN/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
3.0255 of 5 stars
3.21.00.00.01.72.53.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
2.50
Moderate Buy$9.75387.50% Upside
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3.00
Buy$1.2528.47% Upside
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
0.00
N/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
2.33
Hold$6.00131.66% Upside

Current Analyst Ratings Breakdown

Latest PTHL, MLSS, ZYXI, and INO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2025
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$5.00 ➝ $5.00
5/14/2025
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$15.00 ➝ $13.00
4/30/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$5.00 ➝ $4.00
4/30/2025
Zynex, Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $8.00
4/15/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform
3/19/2025
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$6.00 ➝ $5.00
3/19/2025
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.00 ➝ $3.00
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $15.00
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform$11.00 ➝ $5.50
3/12/2025
Zynex, Inc. stock logo
ZYXI
Zynex
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$283.10K259.09N/AN/A$5.16 per share0.39
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$8.61M8.86N/AN/A$0.11 per share8.85
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
$448.20K83.71N/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
$172.40M0.45$0.14 per share18.01$1.36 per share1.90
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-$135.12M-$3.19N/AN/AN/AN/A-118.17%-83.47%8/14/2025 (Estimated)
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-$6.93M-$0.07N/AN/A-52.01%-60.26%-40.23%N/A
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/AN/A0.00N/AN/AN/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
$9.73M-$0.2417.275.51N/A2.49%13.05%3.78%7/23/2025 (Estimated)

Latest PTHL, MLSS, ZYXI, and INO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-$0.74-$0.51+$0.23-$0.51$0.01 million$0.07 million
4/28/2025Q1 2025
Zynex, Inc. stock logo
ZYXI
Zynex
-$0.24-$0.33-$0.09-$0.33$30.83 million$26.58 million
3/18/2025Q4 2024
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-$0.87-$0.69+$0.18-$0.60$0.03 million$0.12 million
3/11/2025Q4 2024
Zynex, Inc. stock logo
ZYXI
Zynex
$0.09-$0.02-$0.11-$0.02$53.65 million$45.98 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
N/AN/AN/AN/AN/A
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/AN/A
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/AN/AN/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
N/A
3.88
3.88
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/A
2.85
1.86
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
1.66
3.94
3.15
CompanyEmployeesShares OutstandingFree FloatOptionable
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
32036.67 million25.45 millionOptionable
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3078.48 million58.61 millionOptionable
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
116.58 millionN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
77030.24 million15.25 millionOptionable

Recent News About These Companies

Here’s Why Zynex (ZYXI) Fell in Q1

New MarketBeat Followers Over Time

Media Sentiment Over Time

Inovio Pharmaceuticals stock logo

Inovio Pharmaceuticals NASDAQ:INO

$2.00 +0.03 (+1.52%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$2.02 +0.02 (+0.75%)
As of 08:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Milestone Scientific stock logo

Milestone Scientific NYSE:MLSS

$0.97 -0.02 (-2.21%)
Closing price 05/27/2025 03:57 PM Eastern
Extended Trading
$0.98 +0.01 (+0.82%)
As of 05/27/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Pheton Holdings Ltd Class A Ordinary Shares stock logo

Pheton Holdings Ltd Class A Ordinary Shares NASDAQ:PTHL

$5.70 -0.85 (-12.98%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$5.78 +0.08 (+1.40%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

Zynex stock logo

Zynex NASDAQ:ZYXI

$2.59 +0.20 (+8.37%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$2.58 0.00 (-0.19%)
As of 05/27/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.